Susquehanna International Group, LLP Crispr Therapeutics Ag Put Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	SELL	$51.17 - $68.18 $4.35 Million - $5.8 Million	-85,100 Reduced 15.05%	480,400 $25.9 Million
Q1 2024 May 07, 2024	BUY	$60.67 - $89.12 $7.47 Million - $11 Million	123,200 Added 27.85%	565,500 $38.5 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $8.16 Million - $15.2 Million	211,200 Added 91.39%	442,300 $27.7 Million
Q3 2023 Nov 14, 2023	SELL	$45.39 - $59.0 $1.42 Million - $1.85 Million	-31,300 Reduced 11.93%	231,100 $10.5 Million
Q2 2023 Aug 11, 2023	BUY	$43.47 - $67.77 $1.5 Million - $2.34 Million	34,600 Added 15.19%	262,400 $14.7 Million
Q1 2023 May 16, 2023	BUY	$41.0 - $56.12 $1.12 Million - $1.53 Million	27,200 Added 13.56%	227,800 $10.3 Million
Q4 2022 Feb 14, 2023	SELL	$39.19 - $65.67 $121,489 - $203,577	-3,100 Reduced 1.52%	200,600 $8.15 Million
Q3 2022 Nov 14, 2022	SELL	$61.1 - $83.78 $8.13 Million - $11.2 Million	-133,100 Reduced 39.52%	203,700 $13.3 Million

503

57M

1.7M

1.8M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.03B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.